140 related articles for article (PubMed ID: 28881733)
21. New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma.
Shair KHY; Reddy A; Cooper VS
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29561768
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
23. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Liu YP; Tan YN; Wang ZL; Zeng L; Lu ZX; Li LL; Luo W; Tang M; Cao Y
Int J Mol Med; 2008 Feb; 21(2):153-62. PubMed ID: 18204781
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
27. LMP1 Up-regulates Calreticulin to Induce Epithelial-mesenchymal Transition via TGF-β/Smad3/NRP1 Pathway in Nasopharyngeal Carcinoma Cells.
Ye D; Zhu J; Zhao Q; Ma W; Xiao Y; Xu G; Zhang Z
J Cancer; 2020; 11(5):1257-1269. PubMed ID: 31956372
[No Abstract] [Full Text] [Related]
28. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells.
Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM
J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
[TBL] [Abstract][Full Text] [Related]
30. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
[TBL] [Abstract][Full Text] [Related]
31. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines.
Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y
Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487
[TBL] [Abstract][Full Text] [Related]
32. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma.
Codd JD; Salisbury JR; Packham G; Nicholson LJ
J Pathol; 1999 Apr; 187(5):549-55. PubMed ID: 10398120
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
[TBL] [Abstract][Full Text] [Related]
34. Autoactivation of the Epstein-Barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kappaB and JNK signaling pathways.
Goormachtigh G; Ouk TS; Mougel A; Tranchand-Bunel D; Masy E; Le Clorennec C; Feuillard J; Bornkamm GW; Auriault C; Manet E; Fafeur V; Adriaenssens E; Coll J
J Virol; 2006 Aug; 80(15):7382-93. PubMed ID: 16840319
[TBL] [Abstract][Full Text] [Related]
35. [Structural and functional features of Epstein-Barr virus LMP-1 gene in patients with anaplastic carcinoma of the nasopharynx in Russia].
Gurtsevich VE; Shcherbak LN; Novikova EV; Hahn P; Belousova NV; Arkhipov VV; Grasser FA; Müller-Lantzsch N; Pavlish OA
Vestn Ross Akad Med Nauk; 2002; (1):53-9. PubMed ID: 11882974
[TBL] [Abstract][Full Text] [Related]
36. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells.
Chang SH; Chang HC; Hung WC
Oral Oncol; 2008 Sep; 44(9):891-7. PubMed ID: 18289921
[TBL] [Abstract][Full Text] [Related]
38. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
[TBL] [Abstract][Full Text] [Related]
39. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]